Use of High-Resolution Microendoscopy (HRME) in Patients With Adenocarcinoma In-Situ (AIS) of the Cervix
Condition(s):Cervix CarcinomaLast Updated:July 25, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Cervix CarcinomaLast Updated:July 25, 2022Completed
Condition(s):Non-small Cell Lung Cancer Stage I; Lung AdenocarcinomaLast Updated:December 16, 2013Unknown status
Condition(s):Lung Adenocarcinoma; Frozen Section; Sublobar ResectionLast Updated:December 13, 2023Recruiting
Condition(s):Cervical Cancer; Cervical Intraepithelial Neoplasia; Adenocarcinoma in SituLast Updated:November 28, 2018Completed
Condition(s):HSIL, High-Grade Squamous Intraepithelial Lesions; Adenocarcinoma in Situ; Early Cervical CancerLast Updated:November 22, 2023Active, not recruiting
Condition(s):Prostate Cancer Adenocarcinoma in SituLast Updated:March 28, 2019Completed
Condition(s):Cervical Cancer; Precancerous ConditionLast Updated:March 8, 2019Completed
Condition(s):Prevention of HPV Types 16- and 18-related Cervical Cancer, Cervical Intraepithelial Neoplasia (CIN) 1/2/3, and Cervical Adenocarcinoma in SituLast Updated:November 14, 2023Completed
Condition(s):Cervical Intraepithelial Neoplasia Grade 2/3; Adenocarcinoma in SituLast Updated:April 23, 2021Enrolling by invitation
Condition(s):Cervical Cancer; Genital WartsLast Updated:September 25, 2015Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.